August 27, 2021
August 27, 2021 - The Assistant Secretary for Preparedness and Response (ASPR) and the U.S. FDA have announced updates to emergency use authorization
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Health Insurance
August 25, 2021
August 25, 2021 – The U.S. FDA has approved Skytrofa® (lonapegsomatropin-tcgd) to treat pediatric patients who are at least one year old, weigh at least 11.5kg
August 25, 2021
August 25, 2021 – The U.S. FDA has granted a new indication to Tibsovo® (ivosidenib tablets) for use in
adults who have previously treated
August 24, 2021
August 24, 2021 – Xarelto® (rivaroxaban) is now approved for use with aspirin to reduce the risk of sudden
decrease in blood flow to the legs, major amputation
August 23, 2021
August 23, 2021 – Pfizer and BioNTech have received full FDA approval for their vaccine to prevent COVID-19 in individuals who are at least 16 years old. The vaccine
August 20, 2021
August 20, 2021 – The U.S. FDA has approved Opdivo® (nivolumab) as an adjuvant treatment for patients who have urothelial carcinoma and are at high risk of
August 18, 2021
August 18, 2021 – Jardiance® (empagliflozin) 10mg, manufactured by Boehringer Ingelheim and Eli Lilly, is now U.S. FDA approved to reduce the risk of cardiovascular death plus hospitalization
August 17, 2021
August 17, 2021 – The U.S. FDA has approved a new indication for Jemperli® (dostarlimab-gxly), manufactured by GlaxoSmithKline. The drug is now